Macclesfield, United Kingdom

Christopher Thomas Halsall

USPTO Granted Patents = 7 


Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 20(Granted Patents)


Location History:

  • Lancashire, GB (2004 - 2007)
  • Macclesfield, GB (2009 - 2010)
  • Cheshire, GB (2014)

Company Filing History:


Years Active: 2004-2014

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Christopher Thomas Halsall: Innovator in Quinazoline Derivatives

Introduction

Christopher Thomas Halsall is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of quinazoline derivatives. With a total of seven patents to his name, Halsall's work focuses on creating compounds that can serve as effective treatments for various diseases, including certain types of cancer.

Latest Patents

Halsall's latest patents include innovative quinazoline derivatives that act as tyrosine kinase inhibitors. These compounds are designed to provide an anti-proliferative effect, making them potentially useful in treating diseases mediated by erbB receptor tyrosine kinases, such as EGFR tyrosine kinase. Another patent involves quinazoline derivatives that serve as antiproliferative agents, aimed at preventing or treating tumors sensitive to erbB receptor tyrosine kinase inhibition. These inventions highlight Halsall's commitment to advancing medical science through innovative chemical solutions.

Career Highlights

Christopher Thomas Halsall is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on the research and development of new therapeutic agents, contributing to the company's mission of improving patient outcomes through innovative medicines.

Collaborations

Halsall has collaborated with esteemed colleagues, including Laurent Francois Andre Hennequin and Michael Wardleworth. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking innovations in the pharmaceutical industry.

Conclusion

Christopher Thomas Halsall is a distinguished inventor whose work in quinazoline derivatives has the potential to transform cancer treatment. His contributions to AstraZeneca and collaborations with fellow researchers underscore his dedication to advancing medical science. Through his innovative patents, Halsall continues to make a significant impact in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…